A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma

Condition:   Renal Cell Carcinoma Metastatic Interventions:   Drug: Abemaciclib;   Drug: Sunitinib Sponsors:   Milton S. Hershey Medical Center;   Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials